Found 4 matching trials
Specific Immunotherapy With Recombinant Birch Pollen Allergen rBet v1-FV
PHASE2Specific immunotherapy with recombinant birch pollen allergen rBet v1-FV...
Location
Allergopharma GmbH & Co. KG
Dose Range Finding Study With rBet v1-FV - in Adult Patients With Birch Pollen-Allergic Seasonal Rhinoconjunctivitis
PHASE2The purpose of this study is to find out if rBet v1-FV works to relieve Sea...
Location
Allergopharma GmbH & Co. KG
Efficacy and Safety From a Recombinant Folding Variant of Bet v 1
PHASE3Efficacy and Safety from a recombinant folding variant of Bet v 1...
Location
Allergopharma GmbH & Co. KG
Immunological and Histological Evaluation of Specific Immunotherapy With Recombinant Hypoallergenic Derivative
PHASE2This trial is performed for the immunological and histological evaluation o...
Location
Prof. Dr. med. Sabina Rak